NCT01171898 2026-02-24
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Aragon Pharmaceuticals, Inc.
Phase 1/2 Completed
Clinical Trials
8 trialsNCT04060394 2024-10-10
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Laekna Limited
Phase 1/2 Completed
NCT00547339 2022-12-07
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT03655834 2022-05-10
IMPROVE-III
Radboud University Medical Center
Phase 4 Completed
NCT03919682 2021-08-26
BCED
Brigham and Women's Hospital
Phase NA Completed
NCT03411161 2021-05-25
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
Servier
Phase 1/2 Completed
NCT03676270 2021-01-07
Phase 1
Institut Bergonié
Completed
NCT01572519 2020-11-20
A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1 Completed